225 related articles for article (PubMed ID: 22878643)
1. The adenosine A3 receptor agonist Cl-IB-MECA induces cell death through Ca²⁺/ROS-dependent down regulation of ERK and Akt in A172 human glioma cells.
Kim TH; Kim YK; Woo JS
Neurochem Res; 2012 Dec; 37(12):2667-77. PubMed ID: 22878643
[TBL] [Abstract][Full Text] [Related]
2. Effects of synthetic A3 adenosine receptor agonists on cell proliferation and viability are receptor independent at micromolar concentrations.
Mlejnek P; Dolezel P; Frydrych I
J Physiol Biochem; 2013 Sep; 69(3):405-17. PubMed ID: 23184730
[TBL] [Abstract][Full Text] [Related]
3. Thio-Cl-IB-MECA, a novel A₃ adenosine receptor agonist, suppresses angiogenesis by regulating PI3K/AKT/mTOR and ERK signaling in endothelial cells.
Kim GD; Oh J; Jeong LS; Lee SK
Biochem Biophys Res Commun; 2013 Jul; 437(1):79-86. PubMed ID: 23791876
[TBL] [Abstract][Full Text] [Related]
4. Cl-IB-MECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation.
Morello S; Petrella A; Festa M; Popolo A; Monaco M; Vuttariello E; Chiappetta G; Parente L; Pinto A
Cancer Biol Ther; 2008 Feb; 7(2):278-84. PubMed ID: 18059189
[TBL] [Abstract][Full Text] [Related]
5. A novel adenosine analog, thio-Cl-IB-MECA, induces G0/G1 cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells.
Lee EJ; Min HY; Chung HJ; Park EJ; Shin DH; Jeong LS; Lee SK
Biochem Pharmacol; 2005 Sep; 70(6):918-24. PubMed ID: 16051194
[TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cells.
Mlejnek P; Dolezel P; Kosztyu P
J Cell Physiol; 2012 Feb; 227(2):676-85. PubMed ID: 21520073
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial and caspase pathways are involved in the induction of apoptosis by IB-MECA in ovarian cancer cell lines.
Abedi H; Aghaei M; Panjehpour M; Hajiahmadi S
Tumour Biol; 2014 Nov; 35(11):11027-39. PubMed ID: 25095978
[TBL] [Abstract][Full Text] [Related]
8. Suppression of inflammation response by a novel A₃ adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-κB signaling.
Lee HS; Chung HJ; Lee HW; Jeong LS; Lee SK
Immunobiology; 2011 Sep; 216(9):997-1003. PubMed ID: 21514967
[TBL] [Abstract][Full Text] [Related]
9. Kaempferol induces cell death through ERK and Akt-dependent down-regulation of XIAP and survivin in human glioma cells.
Jeong JC; Kim MS; Kim TH; Kim YK
Neurochem Res; 2009 May; 34(5):991-1001. PubMed ID: 18949556
[TBL] [Abstract][Full Text] [Related]
10. Silibinin induces cell death through reactive oxygen species-dependent downregulation of notch-1/ERK/Akt signaling in human breast cancer cells.
Kim TH; Woo JS; Kim YK; Kim KH
J Pharmacol Exp Ther; 2014 May; 349(2):268-78. PubMed ID: 24472723
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cell proliferation through cell cycle arrest and apoptosis by thio-Cl-IB-MECA, a novel A3 adenosine receptor agonist, in human lung cancer cells.
Kim SJ; Min HY; Chung HJ; Park EJ; Hong JY; Kang YJ; Shin DH; Jeong LS; Lee SK
Cancer Lett; 2008 Jun; 264(2):309-15. PubMed ID: 18321638
[TBL] [Abstract][Full Text] [Related]
12. Ciglitazone induces caspase-independent apoptosis through down-regulation of XIAP and survivin in human glioma cells.
Kang DW; Choi CH; Park JY; Kang SK; Kim YK
Neurochem Res; 2008 Mar; 33(3):551-61. PubMed ID: 17940898
[TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis by A3 adenosine receptor agonist N-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide in human leukaemia cells: a possible involvement of intracellular mechanism.
Mlejnek P; Dolezel P
Acta Physiol (Oxf); 2010 Jun; 199(2):171-9. PubMed ID: 20121715
[TBL] [Abstract][Full Text] [Related]
14. Underlying mechanism of quercetin-induced cell death in human glioma cells.
Kim EJ; Choi CH; Park JY; Kang SK; Kim YK
Neurochem Res; 2008 Jun; 33(6):971-9. PubMed ID: 18322795
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis in rat cardiocytes by A3 adenosine receptor activation and its suppression by isoproterenol.
Shneyvays V; Jacobson KA; Li AH; Nawrath H; Zinman T; Isaac A; Shainberg A
Exp Cell Res; 2000 May; 257(1):111-26. PubMed ID: 10854059
[TBL] [Abstract][Full Text] [Related]
16. p53-Independent induction of Fas and apoptosis in leukemic cells by an adenosine derivative, Cl-IB-MECA.
Kim SG; Ravi G; Hoffmann C; Jung YJ; Kim M; Chen A; Jacobson KA
Biochem Pharmacol; 2002 Mar; 63(5):871-80. PubMed ID: 11911839
[TBL] [Abstract][Full Text] [Related]
17. A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells.
Merighi S; Benini A; Mirandola P; Gessi S; Varani K; Leung E; Maclennan S; Borea PA
J Biol Chem; 2005 May; 280(20):19516-26. PubMed ID: 15774470
[TBL] [Abstract][Full Text] [Related]
18. Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor.
Ge ZD; Peart JN; Kreckler LM; Wan TC; Jacobson MA; Gross GJ; Auchampach JA
J Pharmacol Exp Ther; 2006 Dec; 319(3):1200-10. PubMed ID: 16985166
[TBL] [Abstract][Full Text] [Related]
19. A3 adenosine receptor agonist IB-MECA reverses chronic cerebral ischemia-induced inhibitory avoidance memory deficit.
Cheng P; Zhang J; Chu Z; Liu W; Lin H; Wu Y; Zhu J
Eur J Pharmacol; 2022 Apr; 921():174874. PubMed ID: 35278404
[TBL] [Abstract][Full Text] [Related]
20. Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells.
Morello S; Sorrentino R; Porta A; Forte G; Popolo A; Petrella A; Pinto A
J Cell Physiol; 2009 Nov; 221(2):378-86. PubMed ID: 19562684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
